Jacqueline Ramı́rez

Genetic Variants in the <i>UDP-glucuronosyltransferase 1A1</i> Gene Predict the Risk of Severe Neutropenia of Irinotecan

Federico Innocenti, Samir D. Undevia, Lalitha Iyer et al. · Journal of Clinical Oncology · 2004 · 954 citations · Full text

Medicine, Oncology, Pharmacology +17

Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics

Federico Innocenti, Deanna L. Kroetz, Erin G. Schuetz et al. · Journal of Clinical Oncology · 2009 · 262 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity

Charles M. Rudin, Wanqing Liu, Apurva A. Desai et al. · Journal of Clinical Oncology · 2008 · 219 citations · Full text

Medicine, Oncology, Pharmacology +15

Identification, Replication, and Functional Fine-Mapping of Expression Quantitative Trait Loci in Primary Human Liver Tissue

Federico Innocenti, Gregory M. Cooper, Ian B. Stanaway et al. · PLoS Genetics · 2011 · 210 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Federico Innocenti, C. Grimsley, Soma Das et al. · Pharmacogenetics · 2002 · 156 citations

Life Sciences, Genetics, Molecular Genetics +15